
    
      The endpoint is the change to one month of polyphenols treatment of the endothelial function
      measured by the index of hyperemic reactivity.

      The secondary endpoints are changes at one month of supplementation with polyphenols of
      ambulatory blood pressure measurement in 24 hours (MAPA), micro-circulatory responsiveness,
      the speed of the pulse wave and biological measurements (lipid profile, blood glucose,
      fasting insulin, leptin, adiponectin, hs-CRP, 8-isoprostane levels and cellular origin of
      microparticles).
    
  